The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

This week’s Weekly Dose covers new Endocrine Society guidelines on preexisting diabetes in pregnancy and primary aldosteronism screening, a digital asthma management tool that improved symptoms but revealed disparities, public perceptions of physicians using AI, evidence linking GLP-1 receptor agonists to reduced dementia risk, and the FDA’s first approved treatment for chronic hand eczema.